PULSE NEWS WIRE
Clear, Actionable Intelligence
<2 min
Avg Latency
24/5
Coverage

Pulse News Wire translates Japanese corporate disclosures filed with the Tokyo Stock Exchange's TDNet system into clear, structured English for institutional investors, hedge funds, and asset managers. Every article on this page is derived directly from an official TDNet filing — including earnings reports, M&A announcements, share buybacks, dividend declarations, and governance changes. Japanese corporate governance is governed by the Companies Act and the Financial Instruments and Exchange Act; timely translation of these disclosures provides a material information advantage for cross-border investors monitoring Tokyo-listed equities.

This corporate disclosure from COSMO BIO COMPANY,LIMITED was processed by Pulse News Wire on March 17, 2026. It represents a primary source document for Japanese Earnings sector intelligence, translated directly from an official filing submitted to the Tokyo Stock Exchange TDNet system.

COSMO BIO COMPANY: Issues Correction to FY2025/12 Earnings Report

TOKYO, Mar 17 (Pulse News Wire) — COSMO BIO COMPANY,LIMITED (TYO: 3386) issued a correction to its previously filed FY2025/12 earnings report. The company identified numerical or data errors requiring

View all 3386.T disclosures →

Share this disclosure: Share on X Share on LinkedIn